Dysregulation of splicing proteins in head and neck squamous cell carcinoma

Aneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, Gajanan Sathe, Sandip Chavan, Raja Sekhar Nirujogi, Arun H. Patil, Hitendra Solanki, Santosh Renuse, Nandini A. Sahasrabuddhe, Premendu P. Mathur, T. S.Keshava Prasad, Prashant Kumar, Joseph A. Califano, David Sidransky, Akhilesh Pandey, Harsha Gowda, Aditi Chatterjee

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

ABSRTRACT: Signaling plays an important role in regulating all cellular pathways. Altered signaling is one of the hallmarks of cancers. Phosphoproteomics enables interrogation of kinase mediated signaling pathways in biological systems. In cancers, this approach can be utilized to identify aberrantly activated pathways that potentially drive proliferation and tumorigenesis. To identify signaling alterations in head and neck squamous cell carcinoma (HNSCC), we carried out proteomic and phosphoproteomic analysis of HNSCC cell lines using a combination of tandem mass tag (TMT) labeling approach and titanium dioxide-based enrichment. We identified 4,920 phosphosites corresponding to 2,212 proteins in six HNSCC cell lines compared to a normal oral cell line. Our data indicated significant enrichment of proteins associated with splicing. We observed hyperphosphorylation of SRSF protein kinase 2 (SRPK2) and its downstream substrates in HNSCC cell lines. SRPK2 is a splicing kinase, known to phosphorylate serine/arginine (SR) rich domain proteins and regulate splicing process in eukaryotes. Although genome-wide studies have reported the contribution of alternative splicing events of several genes in the progression of cancer, the involvement of splicing kinases in HNSCC is not known. In this study, we studied the role of SRPK2 in HNSCC. Inhibition of SRPK2 resulted in significant decrease in colony forming and invasive ability in a panel of HNSCC cell lines. Our results indicate that phosphorylation of SRPK2 plays a crucial role in the regulation of splicing process in HNSCC and that splicing kinases can be developed as a new class of therapeutic target in HNSCC.

Original languageEnglish (US)
Pages (from-to)219-229
Number of pages11
JournalCancer Biology and Therapy
Volume17
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Protein Splicing
Protein Kinases
Cell Line
Phosphotransferases
Carcinoma, squamous cell of head and neck
Neoplasms
Alternative Splicing
Eukaryota
Proteomics
Serine
Arginine
Carcinogenesis
Proteins
Phosphorylation
Genome

Keywords

  • GeneSpring
  • in vitro labeling
  • mRNA processing
  • phosphorylation
  • spliceosome
  • SR proteins

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Radhakrishnan, A., Nanjappa, V., Raja, R., Sathe, G., Chavan, S., Nirujogi, R. S., ... Chatterjee, A. (2016). Dysregulation of splicing proteins in head and neck squamous cell carcinoma. Cancer Biology and Therapy, 17(2), 219-229. https://doi.org/10.1080/15384047.2016.1139234

Dysregulation of splicing proteins in head and neck squamous cell carcinoma. / Radhakrishnan, Aneesha; Nanjappa, Vishalakshi; Raja, Remya; Sathe, Gajanan; Chavan, Sandip; Nirujogi, Raja Sekhar; Patil, Arun H.; Solanki, Hitendra; Renuse, Santosh; Sahasrabuddhe, Nandini A.; Mathur, Premendu P.; Prasad, T. S.Keshava; Kumar, Prashant; Califano, Joseph A.; Sidransky, David; Pandey, Akhilesh; Gowda, Harsha; Chatterjee, Aditi.

In: Cancer Biology and Therapy, Vol. 17, No. 2, 01.02.2016, p. 219-229.

Research output: Contribution to journalArticle

Radhakrishnan, A, Nanjappa, V, Raja, R, Sathe, G, Chavan, S, Nirujogi, RS, Patil, AH, Solanki, H, Renuse, S, Sahasrabuddhe, NA, Mathur, PP, Prasad, TSK, Kumar, P, Califano, JA, Sidransky, D, Pandey, A, Gowda, H & Chatterjee, A 2016, 'Dysregulation of splicing proteins in head and neck squamous cell carcinoma', Cancer Biology and Therapy, vol. 17, no. 2, pp. 219-229. https://doi.org/10.1080/15384047.2016.1139234
Radhakrishnan A, Nanjappa V, Raja R, Sathe G, Chavan S, Nirujogi RS et al. Dysregulation of splicing proteins in head and neck squamous cell carcinoma. Cancer Biology and Therapy. 2016 Feb 1;17(2):219-229. https://doi.org/10.1080/15384047.2016.1139234
Radhakrishnan, Aneesha ; Nanjappa, Vishalakshi ; Raja, Remya ; Sathe, Gajanan ; Chavan, Sandip ; Nirujogi, Raja Sekhar ; Patil, Arun H. ; Solanki, Hitendra ; Renuse, Santosh ; Sahasrabuddhe, Nandini A. ; Mathur, Premendu P. ; Prasad, T. S.Keshava ; Kumar, Prashant ; Califano, Joseph A. ; Sidransky, David ; Pandey, Akhilesh ; Gowda, Harsha ; Chatterjee, Aditi. / Dysregulation of splicing proteins in head and neck squamous cell carcinoma. In: Cancer Biology and Therapy. 2016 ; Vol. 17, No. 2. pp. 219-229.
@article{ed3188f3b5884111a8c633e1ff9c9024,
title = "Dysregulation of splicing proteins in head and neck squamous cell carcinoma",
abstract = "ABSRTRACT: Signaling plays an important role in regulating all cellular pathways. Altered signaling is one of the hallmarks of cancers. Phosphoproteomics enables interrogation of kinase mediated signaling pathways in biological systems. In cancers, this approach can be utilized to identify aberrantly activated pathways that potentially drive proliferation and tumorigenesis. To identify signaling alterations in head and neck squamous cell carcinoma (HNSCC), we carried out proteomic and phosphoproteomic analysis of HNSCC cell lines using a combination of tandem mass tag (TMT) labeling approach and titanium dioxide-based enrichment. We identified 4,920 phosphosites corresponding to 2,212 proteins in six HNSCC cell lines compared to a normal oral cell line. Our data indicated significant enrichment of proteins associated with splicing. We observed hyperphosphorylation of SRSF protein kinase 2 (SRPK2) and its downstream substrates in HNSCC cell lines. SRPK2 is a splicing kinase, known to phosphorylate serine/arginine (SR) rich domain proteins and regulate splicing process in eukaryotes. Although genome-wide studies have reported the contribution of alternative splicing events of several genes in the progression of cancer, the involvement of splicing kinases in HNSCC is not known. In this study, we studied the role of SRPK2 in HNSCC. Inhibition of SRPK2 resulted in significant decrease in colony forming and invasive ability in a panel of HNSCC cell lines. Our results indicate that phosphorylation of SRPK2 plays a crucial role in the regulation of splicing process in HNSCC and that splicing kinases can be developed as a new class of therapeutic target in HNSCC.",
keywords = "GeneSpring, in vitro labeling, mRNA processing, phosphorylation, spliceosome, SR proteins",
author = "Aneesha Radhakrishnan and Vishalakshi Nanjappa and Remya Raja and Gajanan Sathe and Sandip Chavan and Nirujogi, {Raja Sekhar} and Patil, {Arun H.} and Hitendra Solanki and Santosh Renuse and Sahasrabuddhe, {Nandini A.} and Mathur, {Premendu P.} and Prasad, {T. S.Keshava} and Prashant Kumar and Califano, {Joseph A.} and David Sidransky and Akhilesh Pandey and Harsha Gowda and Aditi Chatterjee",
year = "2016",
month = "2",
day = "1",
doi = "10.1080/15384047.2016.1139234",
language = "English (US)",
volume = "17",
pages = "219--229",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Dysregulation of splicing proteins in head and neck squamous cell carcinoma

AU - Radhakrishnan, Aneesha

AU - Nanjappa, Vishalakshi

AU - Raja, Remya

AU - Sathe, Gajanan

AU - Chavan, Sandip

AU - Nirujogi, Raja Sekhar

AU - Patil, Arun H.

AU - Solanki, Hitendra

AU - Renuse, Santosh

AU - Sahasrabuddhe, Nandini A.

AU - Mathur, Premendu P.

AU - Prasad, T. S.Keshava

AU - Kumar, Prashant

AU - Califano, Joseph A.

AU - Sidransky, David

AU - Pandey, Akhilesh

AU - Gowda, Harsha

AU - Chatterjee, Aditi

PY - 2016/2/1

Y1 - 2016/2/1

N2 - ABSRTRACT: Signaling plays an important role in regulating all cellular pathways. Altered signaling is one of the hallmarks of cancers. Phosphoproteomics enables interrogation of kinase mediated signaling pathways in biological systems. In cancers, this approach can be utilized to identify aberrantly activated pathways that potentially drive proliferation and tumorigenesis. To identify signaling alterations in head and neck squamous cell carcinoma (HNSCC), we carried out proteomic and phosphoproteomic analysis of HNSCC cell lines using a combination of tandem mass tag (TMT) labeling approach and titanium dioxide-based enrichment. We identified 4,920 phosphosites corresponding to 2,212 proteins in six HNSCC cell lines compared to a normal oral cell line. Our data indicated significant enrichment of proteins associated with splicing. We observed hyperphosphorylation of SRSF protein kinase 2 (SRPK2) and its downstream substrates in HNSCC cell lines. SRPK2 is a splicing kinase, known to phosphorylate serine/arginine (SR) rich domain proteins and regulate splicing process in eukaryotes. Although genome-wide studies have reported the contribution of alternative splicing events of several genes in the progression of cancer, the involvement of splicing kinases in HNSCC is not known. In this study, we studied the role of SRPK2 in HNSCC. Inhibition of SRPK2 resulted in significant decrease in colony forming and invasive ability in a panel of HNSCC cell lines. Our results indicate that phosphorylation of SRPK2 plays a crucial role in the regulation of splicing process in HNSCC and that splicing kinases can be developed as a new class of therapeutic target in HNSCC.

AB - ABSRTRACT: Signaling plays an important role in regulating all cellular pathways. Altered signaling is one of the hallmarks of cancers. Phosphoproteomics enables interrogation of kinase mediated signaling pathways in biological systems. In cancers, this approach can be utilized to identify aberrantly activated pathways that potentially drive proliferation and tumorigenesis. To identify signaling alterations in head and neck squamous cell carcinoma (HNSCC), we carried out proteomic and phosphoproteomic analysis of HNSCC cell lines using a combination of tandem mass tag (TMT) labeling approach and titanium dioxide-based enrichment. We identified 4,920 phosphosites corresponding to 2,212 proteins in six HNSCC cell lines compared to a normal oral cell line. Our data indicated significant enrichment of proteins associated with splicing. We observed hyperphosphorylation of SRSF protein kinase 2 (SRPK2) and its downstream substrates in HNSCC cell lines. SRPK2 is a splicing kinase, known to phosphorylate serine/arginine (SR) rich domain proteins and regulate splicing process in eukaryotes. Although genome-wide studies have reported the contribution of alternative splicing events of several genes in the progression of cancer, the involvement of splicing kinases in HNSCC is not known. In this study, we studied the role of SRPK2 in HNSCC. Inhibition of SRPK2 resulted in significant decrease in colony forming and invasive ability in a panel of HNSCC cell lines. Our results indicate that phosphorylation of SRPK2 plays a crucial role in the regulation of splicing process in HNSCC and that splicing kinases can be developed as a new class of therapeutic target in HNSCC.

KW - GeneSpring

KW - in vitro labeling

KW - mRNA processing

KW - phosphorylation

KW - spliceosome

KW - SR proteins

UR - http://www.scopus.com/inward/record.url?scp=84961200061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961200061&partnerID=8YFLogxK

U2 - 10.1080/15384047.2016.1139234

DO - 10.1080/15384047.2016.1139234

M3 - Article

C2 - 26853621

AN - SCOPUS:84961200061

VL - 17

SP - 219

EP - 229

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -